450.155(1)(g)
(g) "Nudity" means the showing of the human male or female genitals, pubic area or buttocks with less than a full opaque covering, or the showing of the female breast with less than a fully opaque covering of any portion thereof below the top of the nipple, or the depiction of covered male genitals in a discernibly turgid state.
450.155(1)(h)
(h) "Person" means any individual, partnership, firm, association, corporation or other legal entity.
450.155(1)(i)
(i) "Sadomasochistic abuse" means the infliction of force, pain or violence upon a person for the purpose of sexual arousal or gratification.
450.155(1)(j)
(j) "Sexual conduct" means acts of masturbation, homosexuality, sexual intercourse or physical contact with a person's clothed or unclothed genitals, pubic area, buttocks or, if such person is a female, breast.
450.155(1)(k)
(k) "Sexual excitement" means the condition of human male or female genitals when in a state of sexual stimulation or arousal.
450.155(1)(L)
(L) "Vending machine" means any mechanical device which automatically dispenses contraceptive articles upon the deposit in it of specified coins in payment for the contraceptive articles.
450.155(2)
(2) Exhibition, display or advertisement of certain vending machines by use of material harmful to minors. 450.155(2)(a)(a) No person with knowledge of the nature of the material and with knowledge of a minor's age, may, for commercial purposes, exhibit, display or advertise by use of any material which is harmful to minors a vending machine that dispenses contraceptive articles.
450.155(2)(b)
(b) Whoever violates
par. (a) may be fined not more than $10,000 or imprisoned for not more than 9 months or both.
450.155 History
History: 1985 a. 146.
450.16
450.16
Sale of contraceptives prohibited in certain areas. 450.16(2)
(2) No person may have in the person's possession or under the person's control, any vending machine that is located in a public school, as specified under
s. 115.01 (1).
450.16(3)
(3) Any person violating this section may be fined not more than $10,000 or imprisoned for not more than 9 months or both.
450.16 History
History: 1985 a. 146.
450.17
450.17
Violations. Each member of the board shall investigate and institute actions for violations of this chapter by any person and for violation of
ch. 961 by pharmacists. The district attorney of the proper county shall promptly prosecute any such violation upon notice from any source.
450.17 History
History: 1985 a. 146;
1995 a. 448.
450.18
450.18
Penalties. Except as otherwise provided in this chapter, any person who violates this chapter or any rule promulgated under the authority of this chapter may be fined not less than $50 nor more than $100 or imprisoned not less than 30 days nor more than 90 days or both.
450.18 History
History: 1985 a. 146.
450.19
450.19
Prescription drug monitoring program. 450.19(1)(ag)
(ag) "Monitored prescription drug" means a substance identified in
s. 961.16,
961.18,
961.20, or
961.22 or a drug identified by the board by rule as having a substantial potential for abuse.
450.19(2)
(2) The board shall establish by rule a program for monitoring the dispensing of monitored prescription drugs. The program shall do all of the following:
450.19(2)(a)
(a) Require a pharmacy or a practitioner to generate a record documenting each dispensing of a monitored prescription drug at the pharmacy or, if the monitored prescription drug is not dispensed at a pharmacy, by the practitioner and to deliver the record to the board, except that the program may not require the generation of a record in any of the following circumstances:
450.19(2)(a)1.
1. A monitored prescription drug is administered directly to a patient.
450.19(2)(a)2.
2. A monitored prescription drug is compounded, packaged, or labeled in preparation for delivery but is not delivered.
450.19(2)(a)3.
3. The prescription order is for a monitored prescription drug that is a substance listed in the schedule in
s. 961.22 and is not a narcotic drug, as defined in
s. 961.01 (15), and the prescription order is for a number of doses that is intended to last the patient 7 days or less.
450.19(2)(b)
(b) Identify specific data elements to be contained in a record documenting the dispensing of a monitored prescription drug, including the method of payment and, subject to
sub. (2m), the name recorded under
s. 450.11 (1b) (bm). In identifying specific data elements, the board shall consider data elements identified by similar programs in other states and shall ensure, to the extent possible, that records generated by the program are easily shared with other states.
450.19 Note
NOTE: Par. (b) is shown as affected by
2013 Wis. Acts 124 and
199 and as merged by the legislative reference bureau under s. 13.92 (2) (i).
450.19(2)(c)
(c) Specify the persons to whom a record may be disclosed and the circumstances under which the disclosure may occur. The rule promulgated under this paragraph shall permit the board to share a record generated by the program with relevant agencies of other states.
450.19(2)(d)
(d) Specify a secure electronic format for delivery of a record generated under the program and authorize the board to grant a pharmacy or practitioner a waiver of the specified format.
450.19(2)(e)
(e) Specify a deadline for the delivery of a record to the board.
450.19(2)(f)
(f) Specify the discipline for failure to comply with rules promulgated under this subsection.
450.19(2)(g)
(g) Maximize the potential for funding the operation of the program with available federal funding sources.
450.19(2m)(a)(a) The rules promulgated under
sub. (2) may not require that a record delivered to the board before 2 years after April 9, 2014, contain the name recorded under
s. 450.11 (1b) (bm).
450.19(2m)(b)
(b) After consultation with representatives of licensed pharmacists and pharmacies, and subject to the approval of the secretary, the board may delay the requirement that a record delivered to the board contain the name recorded under
s. 450.11 (1b) (bm) for an additional period beyond the date specified in
par. (a).
450.19(3)(a)(a) A pharmacy, pharmacist, or practitioner is immune from civil or criminal liability or professional discipline arising from the pharmacy's, pharmacist's, or practitioner's compliance in good faith with this section or with rules promulgated under this section.
450.19(3)(b)
(b) Nothing in this section may be construed to require a pharmacy, pharmacist, or practitioner to obtain, before prescribing or dispensing a monitored prescription drug to a patient, information about the patient that has been collected pursuant to the program established under
sub. (2).
450.19(4)
(4) Records generated under the program under this section are not subject to inspection or copying under
s. 19.35.
450.19 History
History: 2009 a. 362;
2011 a. 260 s.
81;
2013 a. 3,
20,
124,
199; s. 13.92 (2) (i).
450.19 Cross-reference
Cross-reference: See also ch.
Phar 18, Wis. adm. code.
